← Evidence map

ArticleOncoTargets and therapy2011

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC.

Marc S Ballas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21691577